Multiple Sclerosis: Will You Share Promising Research? - Dr. Travis

By Dr. Lori Travis Expert

Rate This

0 comments View Comments

More Videos from Dr. Lori Travis 4 videos in this series

Multiple Sclerosis: Which Treatments Are Available? - Dr. Travis

1 of 4

Multiple Sclerosis: Will You Share Promising Research? - Dr. Travis

2 of 4 : Current video

Multiple Sclerosis: Are There New Oral Medications? - Dr. Travis

3 of 4

What Is Chronic Cerebrospinal Venous Insufficiency? - Dr. Travis

4 of 4

Dr. Travis describes some promising multiple sclerosis (MS) research studies.

Dr. Travis:
MS has a huge amount of research going on and some of the most promising things in my opinion are, there are several studies on oral medications so pill form medications that can help reduce the risk of MS attacks. There is research going on with regards to antibodies that are specifically targeted against certain parts of the immune system and there’s research going on to look at less frequent injections.

Let’s talk about new symptomatic MS therapies. The most recent and newly approved medication is called Ampyra and it is a medication, which is taken to help improve walking in MS. It is effective in about 30-40% of people according to research studies, and it’s a medication that can be taken along with your regular MS medications.

About Dr. Lori Travis, M.D.:
Dr. Travis is a graduate of the University of Arizona Medical School. She completed her neurology residency at The Mayo Clinic in Rochester, Minnesota where she was elected Chief Resident. Dr. Travis is board certified by the American Board of Psychiatry and Neurology. She is currently on faculty at the University of Arizona as a Clinical Assistant Professor of Neurology.

Visit Dr. Travis at Phoenix Neurological Associates